UA128428U - METHOD OF COMPLEX TREATMENT OF IDIOPATHIC LUNG FIBROSIS BY FEGAL STEM CELLS BY MEGADOSES IN COMBINATION WITH TETALENTA TETALENTANE EXTRACTS - Google Patents

METHOD OF COMPLEX TREATMENT OF IDIOPATHIC LUNG FIBROSIS BY FEGAL STEM CELLS BY MEGADOSES IN COMBINATION WITH TETALENTA TETALENTANE EXTRACTS

Info

Publication number
UA128428U
UA128428U UAU201805761U UAU201805761U UA128428U UA 128428 U UA128428 U UA 128428U UA U201805761 U UAU201805761 U UA U201805761U UA U201805761 U UAU201805761 U UA U201805761U UA 128428 U UA128428 U UA 128428U
Authority
UA
Ukraine
Prior art keywords
stem cells
extracts
megadoses
tetalentane
tetalenta
Prior art date
Application number
UAU201805761U
Other languages
Ukrainian (uk)
Inventor
Віктор Мірчович Сірман
Віктор Володимирович Радченко
Володимир Вікторович Радченко
Валерія Вікторівна Сірман
Анатолій Костянтинович Маслюков
Original Assignee
Віктор Мірчович Сірман
Віктор Володимирович Радченко
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Віктор Мірчович Сірман, Віктор Володимирович Радченко filed Critical Віктор Мірчович Сірман
Priority to UAU201805761U priority Critical patent/UA128428U/en
Publication of UA128428U publication Critical patent/UA128428U/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Спосіб комплексного лікування ідіопатичного фіброзу легень включає застосування препаратів, які виготовлені з стовбурових клітин. Препарати готують у вигляді суспензій, що містять мегадози стовбурових клітин фетальної печінки, фетального головного мозку та фетальних легень, а також у вигляді екстрактів з фетального тимусу та плаценти. Після чого підшкірно та/або внутрішньовенно вводять пацієнту вказані суспензії та екстракти на фоні стандартної терапії.The method of complex treatment of idiopathic pulmonary fibrosis involves the use of drugs that are made of stem cells. The preparations are prepared in the form of suspensions containing megadoses of fetal liver stem cells, fetal brain and fetal lungs, as well as fetal thymus and placenta extracts. Subsequently, the following suspensions and extracts are administered subcutaneously and / or intravenously to the patient on a background of standard therapy.

UAU201805761U 2018-05-22 2018-05-22 METHOD OF COMPLEX TREATMENT OF IDIOPATHIC LUNG FIBROSIS BY FEGAL STEM CELLS BY MEGADOSES IN COMBINATION WITH TETALENTA TETALENTANE EXTRACTS UA128428U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201805761U UA128428U (en) 2018-05-22 2018-05-22 METHOD OF COMPLEX TREATMENT OF IDIOPATHIC LUNG FIBROSIS BY FEGAL STEM CELLS BY MEGADOSES IN COMBINATION WITH TETALENTA TETALENTANE EXTRACTS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201805761U UA128428U (en) 2018-05-22 2018-05-22 METHOD OF COMPLEX TREATMENT OF IDIOPATHIC LUNG FIBROSIS BY FEGAL STEM CELLS BY MEGADOSES IN COMBINATION WITH TETALENTA TETALENTANE EXTRACTS

Publications (1)

Publication Number Publication Date
UA128428U true UA128428U (en) 2018-09-10

Family

ID=63709471

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201805761U UA128428U (en) 2018-05-22 2018-05-22 METHOD OF COMPLEX TREATMENT OF IDIOPATHIC LUNG FIBROSIS BY FEGAL STEM CELLS BY MEGADOSES IN COMBINATION WITH TETALENTA TETALENTANE EXTRACTS

Country Status (1)

Country Link
UA (1) UA128428U (en)

Similar Documents

Publication Publication Date Title
CL2019003496A1 (en) Treatment methods for patients with Fabry disease who have kidney failure.
JOP20200156A1 (en) Esketamine for the treatment of depression
EP4324521A3 (en) Treatment of fabry disease in ert-naive and ert-experienced patients
MX2020009856A (en) Rimegepant for cgrp related disorders.
MY191040A (en) Therapy involving antibodies against claudin 18.2 for treatment of cancer
JO3709B1 (en) A pharmaceutical composition or kit for use in treating cancer in a mammal comprising asparaginase and methioninase
WO2016090024A3 (en) Combination therapy for treatment of cancer
GB2546224A (en) Method and composition for producing enhanced anti-inflammatory/ anti-catabolic and regenerative agents from autologous physiological fluid
AU2018326364A1 (en) Methods of enhancing and/or stabilizing cardiac function in patients with Fabry disease
MX2018013873A (en) Nanoliposomal irinotecan for use in treating small cell lung cancer.
JP2015532293A5 (en) Composition for the treatment of heart failure in diabetic patients
UA128428U (en) METHOD OF COMPLEX TREATMENT OF IDIOPATHIC LUNG FIBROSIS BY FEGAL STEM CELLS BY MEGADOSES IN COMBINATION WITH TETALENTA TETALENTANE EXTRACTS
WO2017123667A3 (en) Non-ischemic heart failure treatment by cell therapy
EP4241788A3 (en) Methods of treating basal cell carcinoma and glioblastoma
AR111971A1 (en) METHODS FOR TREATING PATIENTS WITH FABRY'S DISEASE WHO HAVE KIDNEY FAILURE
Dopieraіa Factors connected with the efficacy of total sleep deprivation with sleep phase advance in treatment-resistant depression
UA118435C2 (en) METHOD OF COMPREHENSIVE TREATMENT OF LIVER CYROSIS BY FETAL STEM CELL MEGADOSES IN COMBINATION WITH FETAL TISSUE AND PLACENTA EXTRACTS
UA131466U (en) METHOD OF COMPLEX TREATMENT OF MULTIPLE SCLEROSIS BY MEGADOSES OF FETAL STEM CELLS IN COMBINATION WITH FETAL TISSUE EXTRACTS
UA126019U (en) METHOD OF COMPLEX TREATMENT OF DIABETES 2 TYPE MEGADOSIS OF FETAL STEM CELLS
UA129533U (en) COMPLETE METHOD OF ACCELERATED YOUTH REFINING "GOLDEN VIAL" BY THE APPLICATION OF FETAL STEEL CELL STYLES IN COMBINATION WITH EXTRACTAGOHEN PAIN
Zimmet Metoprolol Prior to Primary PCI: An Old Drug Gets Some New Data
EA201992869A1 (en) WAYS OF TREATMENT OF PATIENTS WITH FABRY DISEASE, WHICH HAVE A KIDNEY FAILURE
Buendia-Roldan et al. C42 SEARCHIN'FOR A CURE: NEW ILD TREATMENTS: Pirfenidone Shows Some Beneficial Effect In Patients With Chronic Hypersensitivity Pneumonitis
Ahmed Effect of Ranolazine and Dronedarone on Isoproterenol induced cardiac dysfunction in rats
EA202091092A1 (en) DOSED ADMINISTRATION SCHEME FOR MOBILIZATION OF HEMOPOETIC STEM CELLS AND PRECURSOR CELLS